J. F. Assimacopoulos- and B. Jeanrenaud, , vol.5, pp.33-41, 1989.

N. Begun, K. E. Sussman, and B. Draznin, Differential effects of diabetes on adipocyte and liver phosphotyrosine and phosphoserine phosphatase activities, Diabetes, vol.40, issue.12, pp.1620-1629, 1991.

O. Blondel, J. Simon, B. Chevalier, and B. Portha, Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect ofvanadate, Am. J. Physiol, vol.258, pp.459-467, 1990.

M. Bollene, M. Miralpeix, F. Ventura, B. Toth, R. Bartrons et al., Oral administration of vanadate to streptozotocin diabetic rats restores the glucose-induced activation of liver ,glycogen synthetase, Bioche1n. J, vol.267, pp.269-271, 1990.

S. M. Brichard, C. J. Bailey, and J. C. Henquin, Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate, Diabetes, vol.39, issue.11, pp.1326-1332, 1990.

S. M. Brichard, L. N. Ongemba, J. Kolanowski, and J. C. Henquin, The influence of vanadate on insuline counter-regulatory hormones in obese fa/fa rats, J. Endocrinol, vol.131, issue.2, pp.185-191, 1991.

M. Brownlee, M. Vlassara, and A. Cerami, Nonenzymatic glycosylation products on collagen covalency trap low density lipoprotein, Diabetes, vol.34, pp.938-941, 1985.

R. F. Burk, Protection against free radical injury by selenoenzymes, Pharmacol. Ther, vol.45, issue.3, pp.383-385, 1990.

A. R. Byrne and L. Kosta, Vanadium in foods and human body fluids and tissues, Sei. Total Environ, vol.10, pp.17-30, 1978.

M. C. Cam, R. A. Pederson, R. W. Brownsey, and J. H. Mcneill, Longterm effectiveness of oral vanadyl sulphate in streptozotocindiabetic rats, Diabetologia, vol.36, issue.3, pp.218-224, 1993.

M. Carreras, A. M. Bassols, J. Carreras, and F. Climent, Effect of vanadate on the glucose-1,6-biphosphate synthetase activities of phosphoglucomutase. Archives of Biochenistry and B1:ophysics, vol.264, pp.155-159, 1988.

R. Cordera, G. Andraghetti, R. A. De-fronzo, and L. Rosseti, Effect of in vivo vanadate treatment on insulin-receptor tyrosine kinase activity in partially pancreatectomized diabetic rats, Endocrinology, vol.126, issue.4, pp.2177-2183, 1990.

G. Cros, J. J. Mongold, J. J. Serrano, S. Ramanadham, and J. H. Mcneill, Effects of vanadyl derivatives on animal models of diabetes, Mol. Cell. Biochem, vol.109, issue.2, pp.163-166, 1992.

, Report of WHO study. Technical report series n°727. Geneva: World Health Organisation, 1985.

J. L. Domingo, M. Gomez, J. M. Llobet, J. Corbella, and C. L. Keen, Improvement of glucose homeostasis by oral vanadyl or vanadate treatment in diabetic rats is accompanied by negative side effects, Phannacol. Toxicol, vol.68, issue.4, pp.249-253, 1991.

J. L. Domingo, M. Gomez, D. J. Sanchez, J. M. Llobet, and C. L. Keen, Tiron administration minimizes the toxicity of vanadate but not its insulin mimetics properties in diabetics rats, Life Sei, vol.50, issue.18, pp.1311-1317, 1992.

J. L. Domingo, J. M. Llobet, and J. Corbella, Toxic effets of vanadium in streptozotocin-treated rats after administration of vanadate to normalize blood glucose levels, Diabetologia, vol.33, issue.1, pp.62-63, 1990.

P. Dorosz, Guide pratique des médicaments. 1994-Editions Maloine

G. Fantus, G. Deragon, and B. I. Posner, Effet insulinomimétique du vanadate et du pervanadate: potentiel thérapeutique dans le diabète sucré. Médecine/ sciences, vol.7, pp.255-258, 1991.

P. Faure, P. Corticelli, M. J. Richard, I. Arnaud, C. Coudray et al., Lipid peroxidation and trace element status in diabetic ketotic patients: influence of insulin therapy, Clin. Cheni, vol.39, issue.5, pp.789-793, 1993.

P. Faure, A. M. Roussel, S. Halimi, and A. Favier, Zinc status and lipid peroxydation in IDDM with or without retinopathy: response to an oral zinc supplementation. ln Trace Elements in Man and Animals. 1993-Editions Anke

I. Flechner, K. Maruta, V. Burkart, K. Kawai, H. Kolb et al., Effects of radical scavengers on the development of experimental diabetes, Diabetes Res, vol.13, issue.2, pp.67-73, 1990.

P. Gillery, J. C. Monboisse, F. X. Maquart, and J. P. Borel, Mécanismes de vieillissement des protéines, Diabète Métab, vol.17, issue.1, pp.1-16, 1991.

A. Grimaldi, C. Sachon, and F. Bosquet, Les diabètes: comprendre pour traiter. 1993-Editions médicales internationales. I

G. Grupp, I. Grupp, and C. L. Johnson, Effect of vanadate on cardiac contraction and adenylate cyclase, Biochem. Biophys. Commun, vol.88, pp.440-447, 1979.
DOI : 10.1016/0006-291x(79)92068-0

M. Guerre-millo, I. Haimault, and . Lavau, Données récentes sur la régulation du transport et des transporteurs du glucose dans les tissus insulino-sensibles. Diabète et métabolisme, vol.15, pp.211-223, 1989.

J. C. Guilland and B. Lequeu, Les vitamines, du nutriment au médicament. 1992-Editions médicales internationales

F. G. Hamel, S. S. Solomon, A. S. Jespersen, A. Blotcky, E. Rack et al., Alteration of tissue vanadium content in diabetes, vol.42, pp.1503-1505, 1993.
DOI : 10.1016/0026-0495(93)90142-b

H. , P. De-biochimie, D. K. Granner, P. A. Mayes, R. K. Murray et al., , p.1989

W. R. Harris, S. E. Friedman, and D. Silberman, Behavior of vanadate and vanadyl ion in canine blood, Journal of inorganic Biochemistry, vol.20, pp.157-169, 1984.

J. C. Henquin and S. M. Brichard, Place du vanadium dans le traitement du diabète. Données expérimentales et applications cliniques. Presse Méd, vol.21, pp.1100-1101, 1992.

C. Hermenegildo, A. Raya, J. Roma, and F. J. Romero, Decreased glutathione peroxydase activity in sciatic nerve of alloxan-induced diabetic mice and its correlation with blood glucose levels, Neurocheni. Res, vol.18, issue.8, pp.893-896, 1993.

C. E. Heyliger, A. G. Tahiliani, and J. H. Mcneill, Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats, Science, vol.227, pp.1474-1477, 1985.

C. Roller, F. Ulberth, W. Osterode, and K. Irsigler, Selenium-status and serum levels of the antioxydant vitamins all-trans retinol, ascorbic acid and alpha-tocopherol in diabetic patients with and without retinopathy, Bioavailability, pp.235-238, 1993.

T. G. Hudson, Vanadium: toxicology and biological signifiance. ln Elsevier monogaphs on taxie agents, 1964.

J. V. Hunt and S. P. Wolff, Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radie, Res. Commun, vol.1, pp.115-123, 1991.

Y. Iizuka, E. Sakurai, and N. Hikichi, Effects of selenium on the serum glucose and insulin levels in diabetic rats

, Nippon Yakurigaku Zasshi, vol.100, issue.2, pp.151-156, 1992.

D. Janeczko, A. Czyzyk, J. Kopczynski, and M. Krzyzanowski, Risk factors of cardiovascular death in diabetic patients, Diabet. Med, vol.8, pp.8100-8103, 1991.

T. M. Johnson, M. H. Meisler, M. I. Bennett, and G. R. Willsky, Vanadate induction of pancreatic amylase mRNA in diabetic rats, Diabetes, vol.39, issue.6, pp.757-759, 1990.

G. Jurgens, H. F. Hoff, G. Chisolm, and H. Esterbaeur, Modification of human serum LDL by oxidation, characterization and pathophysiological implications, Chem. Phys. Lip, vol.45, pp.315-336, 1987.

W. Kahler, B. Kuklinski, C. Ruhlmann, and C. Plotz, Diabetes mellitus-a free radical associated disease-Results of adjuvant antioxydant supplementation

, Z. Gesamte. lm. Med, vol.48, issue.5, pp.223-232, 1993.

A. Kanthasamy, N. Sekar, and S. Govindasamy, Vanadate substitute insuline role in chronic experimental diabetes, Indian Journal of Experimental Biology, vol.26, pp.778-780, 1988.

J. W. Lohr, M. I. Bennett, M. A. Pochal, J. Mcreynolds, M. Acara et al., Effect of vanadate on renal hypertrophy and sorbitol accumulation in streptozotocin induced diabetes in rats, Res. Commun. Chem. Pathol. Pharmacol, vol.72, issue.2, pp.1991-202, 1991.

K. L. Madsen, V. M. Porter, and R. N. Fedorak, Oral vanadate reduces N;a+-dependent glucose transport in rat small intestine, Diabetes, vol.48, issue.8, pp.1126-1132, 1993.

W. Malorni, R. Masella, M. T. Santini, F. Iosi, P. Samoggia et al., Human eruthrocyte insulin receptor is affected by the oxidizing agent menadione, Exp. Cell. Res, vol.206, pp.195-203, 1993.

E. J. Masoro and R. J. Mccarter, Aging as a consequence of fuel utilisation, Aging Milano, vol.3, issue.2, pp.117-128, 1991.

J. H. Mcneill, H. L. Delgatty, and M. L. Battell, Insulinlike effects of sodium selenate in streptozotocin-induced diabetic rats, Diabetes, vol.40, issue.12, pp.1675-1678, 1991.

J. H. Mcneill, V. G. Yuen, H. R. Hoveyda, and C. Orvig, Bis (maltolato) oxovanadium (IV) is a patent insuli mimic, J. Med. Chem, vol.35, issue.8, pp.1489-1491, 1992.

J. F. Mead, Free radical mechanisms of lipid damage and consequences for cellular membranes, vol.1, pp.51-68, 1976.

M. Miralpeix, E. Carballo, R. Bartrons, K. Crepin, L. Hue et al., Oral administration of vanadate to diabetic rats restores liver 6-phosphofructo-2-kinase content and mRNA, Diabetologia, vol.35, issue.3, pp.243-248, 1992.

M. Miralpeix, J. K. Decaux, A. Kahn, and R. Bartrons, Vanadate induction of L-type pyruvate kinase mRNA in adult rat hepatocytes in primary culture, Diabetes, vol.40, pp.462-464, 1991.

J. C. Monboisse, P. Gillery, F. X. Maquart, and J. P. Borel, Production of superoxide anion by glycated proteins: involvement in complications of diabetes mellitus, Adu. Exp. Med. Biol, vol.264, pp.551-554, 1990.

J. H. Mongold, G. H. Cros, L. Vian, A. Tep, S. Ramanadham et al., Toxicological aspects of vanq.dyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cells morphology, Pharrnacology and Toxicology, vol.67, pp.192-198, 1990.

C. J. Mullarkey, D. Edelstein, and M. Brownlee, Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes, Biochem. Biophys. Res. Com1nun, vol.173, issue.3, pp.932-939, 1990.

B. R. Nechay, Mechanism of action of vanadium, Ann. Rev. Pharmacol. Toxicol, vol.24, pp.501-524, 1984.

J. Neve, Physiological and nutritional importance of selenium, Experientia, vol.47, issue.2, pp.187-193, 1991.

J. Neve, M. Henry, A. Peretz, and J. P. Mareschi, L'importance nutritionnelle du sélénium, Cah. Nutr. Diet, vol.22, issue.2, pp.145-162, 1987.

J. Neve, P. Therond, and . Le, ln Les oligoéléments en médecine et biologie. 1991-Editions médicales internationales

F. H. Nielsen, Vanadium. ln Mertz W.(Ed.) Trace elements in human and animal nutrition-Fifth edition, pp.275-300
URL : https://hal.archives-ouvertes.fr/hal-01058388

M. H. Oster, J. M. Llobet, J. L. Domingo, J. B. Gern1an, and C. L. Keen, Vanadium treatment of diabetic Sorague-Dawley rats results in tissue vanadium accululation and pro-oxidants effects, Toxicology, vol.83, issue.1-3, pp.115-130, 1993.
DOI : 10.1016/0300-483x(93)90096-b

G. Paolisso, A. D'amore, D. Giugliano, A. Ceriello, M. Varricchio et al., Pharmacologie doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. A1n, J. Clin. Nutr, vol.57, pp.650-656, 1993.

J. A. Pennington and J. W. Jones, Molybdenum, nickel, cobalt, vanadium and strontium in total diets, J. Am. Diet. Ass, vol.87, pp.1644-1650, 1987.

L. Perlemuter, G. Collin-de-l'hortet, and . Diabétologie, , 1987.

G. M. Pieper, P. Langenstroer, and G. J. Gross, Hydroxyl radicals mediate injury to endothelium-dependent relaxation in diabetic rat, Mol. Cell. Biochem, vol.122, issue.2, pp.139-145, 1993.

S. Pugazhenthi, J. F. Angel, and R. L. Khandelwal, Long-terme effects of vanadate treatment on glycogen metabolizing and lipogenic enzymes of liver in genetically diabetic (db/db) mice, Metabolism, vol.40, issue.9, pp.941-946, 1991.

S. Pugazhenthi and R. L. Khandelwal, Insulinlike effects of vanadate on hepatic glycogen metabolism in non-diabetic and streptozotocininduced diabetic rats, Diabetes, vol.39, pp.821-827, 1990.

S. Pugazhenthi, R. L. Khandelwal, and J. F. Angel, Insulin-like effect of vanadate on malic enzyme and glucose-6-phosphate dehydrogenase activities in streptozotocin-induced diabetic rat liver, Biochern. Biophys. Acta, vol.1083, issue.3, pp.310-312, 1991.

S. Pugazhenthi, S. V. Mantha, and R. L. Khandelwal, Decrease of liver protein kinase C in streptozotocin-induced diabetic rats and restoration by vanadate treatment, Biochem. Int, vol.21, issue.4, pp.651-657, 1990.

S. Ramanadham, R. W. Brownsey, G. H. Cros, J. J. Mongold, and J. H. Mcneill, Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment, vol.38, pp.1022-1028, 1989.

S. Ramanadham, G. H. Cros, J. J. Mongold, J. J. Serrano, and J. H. Mcneill, Enhanced in vivo sensitivity of vanadyl-treated diabetic rats to insulin. Can, J. Physiol. Pharmacol, vol.68, pp.486-491, 1990.

S. Ramanadham, J. J. Mongold, R. W. Brownsey, G. H. Cros, and J. H. Mcneill, Oral vanadyl sulfate in treatment of diabetes mellitus in rats, Am. J. Physiol, vol.257, pp.904-911, 1989.

J. E. Rodriguez-gil, A. M. Gomez-foix, C. Fillat, F. Bosch, and J. J. Guinovart, Activation by vanadate of glycolysis in hepatocytes from diabetic rats, Diabetes, vol.40, issue.10, pp.1355-1359, 1991.

L. Rosseti and M. R. Lauglin, Correction of chronic hyperglycemia with vanadate, but not with phlorizin normalizes in vivo glycogen repletion and in vitro glycogen synthetase activity in diabetic skeletal muscle, J. Clin. Invest, vol.84, pp.892-899, 1989.

D. Rueff, Forme et santé, une révolution: la médecine orthomoléculaire. 1991-Editions du Rocher

E. Sabbioni and E. Marafante, Relation between iron and vanadium metabolism: ·in vivo incorporation of vanadium into iron proteins of the rat, Journal of Toxicology and Environmental Health, vol.8, pp.419-429, 1981.

E. Sabbioni, E. Marafante, L. Amantini, L. Ubertalli, and C. Birattari, Similarity in metabolic patterns of different chemical species of vanadium in the rat, Bioinorg, vol.8, pp.503-515, 1978.

A. K. Saxena, P. Srivastava, and N. Z. Baquer, Effect of vanadate on glycolytic enzymes and malic enzyme in insulin-dependent andindependent tissues of diabetic rats, Eur. J. Phannacol, vol.216, pp.123-126, 1992.

A. K. Saxena, P. Srivastava, R. K. Kale, and N. Z. Baquer, Effect of vanadate administration on polyol pathway in diabetic rat kidney, Biochem. Int, vol.26, issue.1, pp.59-68, 1992.

N. Sekar and S. Govindasamy, Insulin mimetic role of vanadate on plasma membrane insulin-receptors, Biochem. Int, vol.23, issue.3, pp.461-466, 1991.

N. Sekar, A. Kanthasamy, S. William, S. Subramanian, and S. Govindasamy, Insulinic actions of vanadate in diabetic rats, Pharmacol. Res, vol.22, issue.2, pp.207-217, 1990.

Y. Shechter, Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes, Diabetes, vol.39, issue.1, pp.1-5, 1990.

Y. Shechter and A. Shisheva, Vanadium salts and future treatment of diabetes, Endeavour, vol.17, issue.1, pp.27-31, 1993.

A. Shisheva, O. Ikonomov, and Y. Shechter, The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats, Endocrinology, vol.134, issue.1, pp.507-510, 1994.

V. Soska, D. Krusova, B. Podrouzkova, A. Lojek, and A. Zechmeister,

, Unitr. Lek, vol.39, issue.6, pp.569-574, 1993.

J. Spallholz, Selenium and glutathione peroxydase: essential nutrient and antioxydant component of the immune system, Advances and experimental medicine and biology, vol.262, pp.145-167, 1989.

T. C. Stadman, Specific occurence of selenium in enzymes and amino acid t-RNAs, Faseb. J, vol.1, pp.375-379, 1987.

A. Stern, X. Yin, S. S. Tsang, A. Davison, and J. Moon, Vanadium as a modulator of cellular regulatory cascades and oncogene expression, Biochem. Cell. Biol, vol.71, issue.3-4, pp.103-112, 1993.

H. V. Strout, P. P. Vicario, C. Biswas, R. Saperstein, E. J. Brady et al., Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle, Endocrinology, vol.126, issue.5, pp.2728-2732, 1990.

D. Susie and D. Kentera, Dependance of the hypertensive effect of chronic vanadate administration on renal excretory fonction in the rat, Journal of hypertension, vol.6, pp.199-204, 1988.

S. Tamura, T. A. Brown, J. H. Whipple, Y. Fujita-yamaguchi, R. E. Dubler et al., A novel mechanism for the insulin-like effect on glycogen synthetase in rat adipocytes, J. Biol. Chein, vol.259, pp.6650-6658, 1984.

G. Tchobrousky, G. Slama, R. Assan, and P. Freychet,

K. H. Thompson, J. Leichter, and J. H. Mcneill, Studies of vanadyl sulfate as a glucose-lowering agent in STZ-diabetic rats, Biochem. Biophys. Res. Commun, vol.193, issue.3, pp.1549-1555, 1993.

K. H. Thompson and J. H. Mcneill, Effect of vanadyl sulfate feeding on susceptibility to peroxydative change in diabetic rats, Res. Commun. Chem. Pathol. Pharmacol, vol.80, issue.2, pp.187-200, 1993.

E. L. Tolman, E. Barris, M. Burns, A. Pansini, and R. Partridge, Effects of vanadium on glucose metabolism in vitro, Life Sei, vol.25, pp.1159-1164, 1979.

N. Venkatesan, A. Avidan, and M. B. Davidson, Antidiabetic action of vanadyl in rats independent of in vivo insulin-receptor kinase activity, Diabetes, vol.40, issue.4, pp.492-498, 1991.

, Vidal 1994-Editions du Vidal

M. Vilkas, Vitamines: Mécanismes d'action chimique. 1994Editions Hermann

S. P. Wolff, Z. Y. Jiang, and J. V. Hunt, Protein glycation and oxydative stress in diabetes mellitus and ageing. Free Radie, Biol. Med, vol.10, issue.5, pp.339-352, 1991.
DOI : 10.1016/0891-5849(91)90040-a

S. Yadav, J. P. Day, V. Mohan, C. Snehalatha, and J. M. Braganza, Selenium and diabetes in tropics, Pancreas, vol.6, issue.5, pp.528-533, 1991.
DOI : 10.1097/00006676-199109000-00005

V. G. Yuen, C. Orvig, and J. H. Mcneill, Glucose-lowering effects of a new organic vanadium complex, bis (maltolato) oxovanadium (IV)
DOI : 10.1139/y93-041

. Can, J. Physiol. Pharmacol, vol.71, issue.3-4, pp.263-269, 1993.

V. G. Yuen, C. Orvig, K. H. Thomson, and J. H. Mcneill, Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis (maltolato) oxovanadium (IV). Can, J. Physiol. Pharmacol, vol.71, issue.3-4, pp.270-276, 1993.

R. Zawislak and . Le, In Les oligo-éléments en médecine et biologie. 1991-Editions médicales internationales